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ABSTRACT
Saphenous veins are commonly used as coronary artery bypass grafts. There-
fore, it is important to understand the vein wall morphology used for the 
bypass grafts.
Methods. Ten specimens of saphenous veins were obtained from 10 patients 
admitted to the Heart Surgery Centre of P. Stradiņš Clinical University Hos-
pital for coronary artery bypass surgery and a histopathological study was 
conducted. The slides were processed for histological routine and immuno-
histochemical staining with following markers: endothelin (ET), metal-
lomembranoproteinase 2 (MMP2), tissue inhibitor of metalloproteinase 2 
(TIMP2), transforming growth factor beta (TGF β), hepatocyte growth fac-
tor (HGF), vascular endothelial growth factor (VEGF), protein gene product 
9.5 (PGP9.5), vascular cell adhesion molecule (VCAM), intercellular adhe-
sion molecule (ICAM). For the analysis of the positive structures detected by 
immunohistochemistry, a semiquantitative evaluation method was used.
Results. Normal histoarchitecture of the vein wall was evaluated by  routine 
staining. Moderate positive endothelin containing endothelial cells and mod-
erate to numerous positive VEGF cells were found on small blood  vessels. 
Moderate positive MMP2 structures and variable – mainly moderate to 
numerous positive TIMP structures – were found in vein wall. Positive struc-
tures were evaluated as equal with both MMP2 and TIMP, with one excep-
tion where MMP2 positive structures were evaluated as moderate, but TIMP 
positive structures as few. All specimens were rich in TGFβ, VCAM and 
ICAM cells. Abundance of VCAM and ICAM positive endothelial cells was 
also found. Few HGF positive structures were found in tunica intima and few 
PGP9.5 positive nerve fibres in tunica adventitia.
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Conclusions. Rich expression of TGFβ, VCAM, ICAM is characteristic for 
saphenous vein. A number of VEGF, MMP and TIMP positive cells found in 
saphenous vein wall indicates a presence of tissue remodelling and ischemia, 
while low number of HGF positive cells shows its lesser involvement in home-
ostasis regulation.
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INTRODUCTION
Th e venous system constitutes an adaptable and variable system from per-
son to person and, as such, has been an oft en-overlooked part of vascular 
 anatomy. Nonetheless, the continued use of veins in operative techniques such 
as bypasses in addition to highly debilitating manifestations of venous disease 
stresses the importance of understanding the vein wall and the venous system. 
In spite of the common basic function of arteries and veins in transporting 
blood, signifi cant distinctions continue to be found in the organic backgrounds 
of the two types of vessels.
Th e venous wall is composed of three layers, the intima, the media, and the 
adventitia. Th e internal elastic layer further separates the intima and the media, 
and the external elastic layer separates the media and adventitia [1, 2].
Intima. Th e intima consists of one layer of simple squamous epithelium – 
endothelium – sitting on an incomplete elastic basement membrane. Under 
normal healthy conditions, the endothelial cells have essential roles in venous 
wall integrity and function. Th ese cells produce vasorelaxants, such as prosta-
cyclin (PGI 2) and NO, which are known to prevent platelet activation, adhe-
sion, and aggregation. NO also negatively aff ects the expression of chemical 
mediator secretion and infl ammatory cell adhesion molecules including inter-
cellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 
(VCAM-1). [1, 3, 4].
In humans, the intima develops only aft er birth and forms completely by 
6 months of age. Th ere is no defi nite internal elastic lamina and, as in arteries, 
the thickness of the intima increases with age (phlebosclerosis). In arteries the 
earliest signs of atherosclerosis and fatty streaks appear in the areas of sheer 
stress and increased intimal thickness. [4, 5, 6].
Media. Th e media is composed of circularly arranged smooth muscle cells 
and varies greatly according to location. Small veins have only a thin muscu-
lar wall, but in larger channels, such as the saphenous vein and the inferior 
vena cava, there are coarse bundles of irregular muscle, partially organised 
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into  longitudinal and circular layers [1, 5, 7]. However, in general, it is less well 
developed than that of the arterial system. Th is thin media may  contribute 
to the development of varicosities in lower extremity veins. Larger-calibre 
veins have limited contractile capacity in comparison to the thicker-walled 
great saphenous vein [1, 5, 8]. Th e smooth muscle cells of this layer are held 
in a  quiescent state in the normal venous environment by various factors. Th e 
tunica media contains extracellular connective elements (elastin, collagen types 
I and III, proteoglycans, and glycosaminoglycans) and vascular smooth muscle 
cells. Transforming growth factor-β downregulates their mitogenesis and stabi-
lizes the extracellular matrix against smooth muscle cell migration. In addition, 
heparin and heparin-like molecules neutralize the fi broblast growth factor to 
downregulate cell proliferation. Th is process is important because these factors 
keep the normal vessel wall in a state of low cell turnover with low rates of pro-
liferation and apoptosis. Injury or changes to the environment, as when veins 
are exposed to arterial fl ow, can increase the rates of proliferation or apoptosis 
[1, 9, 10].
Adventitia. External to a poorly developed external elastic lamina is the 
adventitia, a loose connection of extracellular matrix with a sparse vasa vaso-
rum. It is generally the thickest layer in large veins. It may sometimes blend 
with the media. Bundles of longitudinally oriented smooth muscle cells are 
interspersed with collagen and elastic fi bres in this layer. Adventitia may con-
tain bundles of longitudinally oriented smooth muscle cells interspersed with 
collagen and elastic fi bres. Th e abundant collagen fi bres have either a longi-
tudinal or helical orientation. Compared with vasa vasorum of the correspond-
ing arteries, vasa vasorum are much more extensive in venous adventitia and 
penetrate into deeper regions of the adventitia as well. Lower oxygen tension in 
venous blood is a possible explanation for this phenomenon [1, 3, 10].
In general, veins have thinner walls than their corresponding  arteries 
because their cellular and fi brous components are typically more  limited 
than those of the arterial system. Th e relevance of the diff erence in the 
media+adventitia thickness is unknown. It should be noted that the com-
position of vein walls is also diff erent, with a relative abundance of collagen 
fi bres, particularly in large veins, and a relative paucity of elastic fi bres – as 
might be assumed from the diminished internal and external elastic laminae. 
Researchers increasingly have recognized the vein graft  tunica adventitia as an 
important repository of progenitor cells which subsequently can migrate and 
proliferate; and as a source of vascular wall infl ammatory cells, cytokines, and 
chemokines. [1, 11, 12, 13].
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Specific factors of the vein wall
Endothelin-1 (ET-1) is the most abundant and important endothelin produced 
by endothelial cells. ET-1 carries out its eff ects through two types of mem-
brane-G protein-coupled receptors, ET A and ET B. Many important func-
tions are mediated by the activation of these receptors, such as cardiovascular 
remodelling, vasoconstriction, cell proliferation and diff erentiation, produc-
tion of extracellular matrix, and water and sodium secretion control. ET recep-
tors can be found on vascular smooth muscle cells, adventitial fi broblasts, and 
endothelial cells. [14, 15, 16].
Matrix metalloproteinases (MMPs), also called matrixins, function in the 
extracellular environment of cells and degrade both matrix and non-matrix 
proteins. Matrix metalloproteinases are produced by smooth muscle cells and 
macrophages to actively modify the matrix. Th ey play central roles in mor-
phogenesis, wound healing, tissue repair and remodelling in response to 
injury. Th ey are multi-domain proteins and their activities are regulated by 
tissue inhibitors of metalloproteinases (TIMPs). In addition to an inhibitory 
role against metalloproteinases, the encoded protein has a unique role among 
TIMP family members in its ability to directly suppress the proliferation of 
endothelial cells. As a result, the encoded protein may be critical to the main-
tenance of tissue homeostasis by suppressing the proliferation of quiescent tis-
sues in response to angiogenic factors, and by inhibiting protease activity in 
tissues undergoing remodelling of the extracellular matrix [16, 17, 18].
Transforming growth factor beta (TGFβ) encoded protein regulates cell 
proliferation, diff erentiation and growth, and can modulate expression and 
activation of other growth factors. TGFβ critically regulates the development 
of neointima formation following vascular injury; however, the underlying sig-
nalling mechanisms remain to be fully elucidated. Two distinct type I TGF-β 
receptors, Alk-1 and Alk-5, are both expressed in endothelial cells and peri-
cytes [17, 18, 19].
Hepatocyte growth factor (HGF) binds to the hepatocyte growth factor 
receptor to regulate cell growth, cell motility and morphogenesis in numer-
ous cell and tissue types. It also plays a role in angiogenesis, tumorogenesis, 
and tissue regeneration. Pleiotropic growth factor has potential angiogenic, 
 anti-apoptotic, antifi brotic and anti-infl ammatory benefi ts [17, 20].
Vascular endothelial growth factor (VEGF) induces proliferation and 
migration of vascular endothelial cells and is essential for both physiological 
and pathological angiogenesis. Furthermore, stretch-induced modulation of 
genes involved in myogenic diff erentiation (VEGF) contributes to the vascular 
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remodelling that underlies pathologic complications, such as neointima devel-
opment and atherosclerosis of the vein graft s. [7, 17, 21].
Protein Gene Product 9.5 (PGP 9.5) is also known as ubiquitin C-terminal 
hydrolase 1 (UCHL-1). Expression of PGP9.5 is highly specifi c to neurons and 
to cells of the diff use neuroendocrine system. Originally isolated as a neuron-
specifi c protein, it also plays important roles in the nonlysosomal proteolytic 
pathway [22, 23].
Vascular cell adhesion molecule 1 (VCAM-1) encodes a cell surface sialo-
glycoprotein expressed by cytokine-activated endothelium. Th is type I mem-
brane protein mediates leukocyte-endothelial cell adhesion and signal trans-
duction and may play a role in the development of atherosclerosis. VCAM-1 
expression has been detected on cell types other than endothelium,  including 
macrophages, dendritic cells, astrocytes, bone marrow stromal cells, and 
 respiratory epithelial cell lines [17, 24].
Intercellular adhesion molecule 1 (ICAM-1) is a member of the immuno-
globulin superfamily of adhesion receptors and is associated with several com-
mon diseases, such as heart disease and stroke. It is a cell surface glycoprotein 
which is typically expressed on endothelial cells and cells of the immune sys-
tem and is involved in the binding of a cell to another cell or to the extracellular 
matrix. Levels of endothelial ICAM-1 expression greatly increase aft er stimu-
lation by cytokines (e.g., IL-1, TNF-α, IFN-γ) or bacterial endotoxin. Th ey have 
roles in cell proliferation, diff erentiation, motility, traffi  cking, apoptosis and 
tissue architecture [17, 24, 25].
Aim of the study
Th e aim of this study was to evaluate morphologic features of healthy saphen-
ous vein used in coronary artery bypass surgery.
MATERIAL AND METHODS
Vein samples were acquired at the Heart Surgery Centre of Pauls Stradiņš 
Clinical University Hospital from patients who were admitted to the hospital 
for coronary artery bypass surgery. Th e patients’ records were retrieved and 
analysed according to a predetermined protocol. 
Ten specimens of saphenous veins were obtained from 10 patients (7 males 
and 3 females) whose age ranged from 55 to 81 years. Th ey had been admitted 
to the Heart Surgery Centre of Pauls Stradiņš Clinical University Hospital for 
coronary artery bypass surgery, and a histopathological study was conducted.
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Th e research was approved by the hospital’s Ethics Committee and local 
Committee of Ethics at Riga Stradiņš University on 22 February 2018. All 
patients were informed about the procedure and the handling of the received 
samples.
Data on vascular risk factors were collected from all patients during their 
visits.
Methods
Two-to three-centimetre-long tissue fragments were taken from operation 
material using the less traumatic technique.
Th e tissue fragments were fi xed for 24 hours in Stefanini solution – a mix-
ture consisting of 2% formaldehyde and 0.2% picric acid in 0.1-M phosphate 
buff er (pH 7.2) (Stefanini et al., 1967) and were subsequently washed for 
12 hours in phosphate buff er (pH 7). Th en, tissues were embedded in paraffi  n 
and 3–4 μm thick sections were prepared by microtome. Th e tissue depar-
affi  nization was carried out with xylene, and the tissue was then dehydrated 
with alcohol 96º. Th e slides were processed for histological routine straining to 
obtain an overview picture as well as immunohistochemical staining using the 
HiDef detection method to identify the following markers in tissue  samples: 
endotelin (mouse, ab-2786, 1:250, Abcam),  metalomembranoproteinase 
2 (MMP2) (mouse, sc-53630, 1:100, Santa Cruz Biotechnology, Inc), tissue 
inhibitor of metalloproteinase 2 (TIMP2) (mouse, sc-21735, 1:200, Santa Cruz 
Biotechnology, Inc), transforming growth factor beta (TGF β) (rabbit, sc-82, 
1:100, Santa Cruz Biotechnology, Inc), hepatocyte growth factor (HGF) (goat, 
f-21, 1:300, RD Systems), vascular endothelial growth factor (VEGF) (rab-
bit, orv-191500, 1:100, Biorbyt), protein gene product 9.5 (PGP9.5) (rabbit, 
439273a, 1:200, Initrogen), vascular cell adhesion molecule (VCAM) (goat, 
cd-106, 1:200, RD Systems), intercellular adhesion molecule (ICAM) (goat, 
cd-54, 1:300, RD Systems).
Tissue samples were rinsed with TRIS buff er (Lot 0713513, Diapath S.p.A., 
Italy) twice for 5 minutes, and placed in boiling EDTA buff er (Lot 0713311, 
Diapath S.p.A., Italy) in a microwave oven for up to 20 minutes. Th e container 
with the samples was then cooled in the buff er for up to 20 minutes, until it 
reached 65 ºC. Th e specimen was placed in a TRIS wash buff er, and blocking 
with peroxidase block (Lot 1213603A, Cell Marque, USA) was performed for 
10 minutes. Th e next steps were rinsing twice for 5 minutes as well as rinsing 
in TRIS wash buff er for 5 minutes.
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For antibodies obtained from goat, the LSAB staining system (Santa Cruz 
Biotechnology, Inc., USA) was used. First, incubation with the primary anti-
body for 2 hours was performed, followed by washing in TRIS wash buff er for 
5 minutes and then incubation for 30 minutes with biotin (secondary anti-
body). Th is process was followed by washing in TRIS buff er for 5 minutes, 
incubation for 30 minutes with the HRP-streptavidin complex, and then wash-
ing in TRIS wash buff er again for 5 minutes. Tissue coating with the liquid 
DAB+ chromogenic substrate system as well as incubation at room tempera-
ture, which together resulted in a positive structure being coloured brown, was 
carried out for up to 10 minutes. Th e sample was then washed in distilled water 
for 5 minutes and counterstained with haematoxylin (Mayer`s haematoxylin, 
Bio Optica Milano S.p.A., Italy) for 2 minutes.
For antibodies obtained from mouse or rabbit, the EnVision staining system 
(Lot 1528902C, Cell Marque, USA) was used. Incubation with the primary 
antibody for 1 hour was followed by washing in TRIS washing buff er twice 
for 5 minutes and the En Vision+/binding phase for 30 minutes. Washing in 
TRIS washing buff er twice was then repeated. Tissue coating with liquid DAB+ 
substrate chromogenic system and incubation at room temperature was per-
formed, resulting in a positive structure having brown coloration; this took 
between 1–10 minutes, aft er which the sample was washed in distilled water 
for 5 minutes and counterstained with haematoxylin (Mayer`s haematoxylin, 
Bio Optica Milano S.p.A., Italy) for 2 minutes.
For the analysis of the positive structures detected by immunohistochemis-
try, a semiquantitative evaluation method was used (Pilmane et al., 2011). Th e 
designations were as follows: 0 – negative reaction; 0/+ – occasionally marked 
structures in the view fi eld; + – a few positive structures in the view fi eld; +/++ – 
a few to moderate number of positive structures in the view fi eld; ++ – a moder-
ate number of positive structures found in the view fi eld; ++/+++ – moderate to 
numerous positive structures; +++ – numerous positive structures in the view 
fi eld; ++++ – abundance of positive structures in view fi eld. Th e evaluation was 
performed with a Leica microscope.
RESULTS
Vein sections revealed normal histoarchitecture of the vein wall composed of 
3 tunicae evaluated in routine staining (Fig.1). Th e fi rst tunica from the lumi-
nal side was the intima, which was fully or partially covered with endothelial 
cells. Tunica intima in all specimens was thin with one exception, where tunica 
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intima was thick, wider than tunica media (Fig.2). Th e media was thick and 
fi lled with smooth muscle cells with one exception where the tunica media was 
thin. Th e tunica adventitia consisted of bundles of collagen fi bres, fi broblasts, 
vasa vasorum, a few of which were sclerotic in all specimens.
Immunohistochemistry results
Moderate (++) positive endothelin containing endothelial cells (Fig. 3) as 
well as moderate to numerous (++/+++) positive VEGF endothelial cells were 
found on small blood vessels. Moderate (++) positive MMP2 endothelial cells, 
smooth muscle cells and fi broblasts (Fig.4) and variable – mainly moderate 
to numerous (++/+++) positive TIMP endothelial cells, smooth muscle cells 
and fi broblasts were found. Despite variability, in all cases positive structures 
were evaluated as equal with both MMP2 and TIMP with one exception where 
MMP2 positive structures were evaluated as moderate (++), but TIMP positive 
structures were evaluated as few (+). All specimens were rich in TGFβ, VCAM 
and ICAM, numerous (+++) TGFβ structures. Abundance (++++) of VCAM 
and ICAM positive endothelial cells was also found. HGF expression was not 
characteristic in veins and only few (+) positive structures were found in tunica 
intima. Few (+) PGP9,5 positive nerve fi bres were found in tunica adventitia.
Figure 1. Note classic picture of v. 
saphena magna wall with three intact 
layers – tunica intima, tunica media 
and tunica adventitia. Hematoxylin and 
 eosin, × 100
Figure 2. As one exception, see hyperplasia of 
tunica intima, where it is thick and wider than 
tunica media. Hematoxylin and eosin, × 100
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Figure 3. Note in this tunica intima frag-
ment moderate (++) positive endothelin 
 containing endothelial cells. Endothelin IMH, 
× 400
Figure 4. Throughout all layers there can 
be seen moderate (++) MMP2 positive 
endothelial cells, smooth muscle cells and 
fi broblasts. MMP2 IMH, × 100
DISCUSSION
Moderate endothelin and moderate to numerous VEGF endothelial cells found 
by us in v.saphena magna wall is characteristic of healthy veins. VEGF is a 
secreted protein; its binding sites are selectively expressed in endothelial cells 
in vitro and in vivo; the expression of its mRNA is correlated to blood vessel 
growth [26]. Endothelin, on the other hand, is considered an important media-
tor in vessel remodelling, ultimately leading to major changes in cellular and 
tissue architecture [21].
Equal number of positive MMP2 and TIMP2 endothelial cells, smooth 
muscle cells and fi broblasts detected in saphenous vein suggests the balance 
between tissue degeneration enzymes and their inhibitors, while any exception 
to this model might be a deviation from the ontogenetic norm and plays an 
important role in vein bypass graft  functionality. Mid-term and late saphenous 
vein graft  failure is determined by formation of the neointima [27]. Although, 
many local and systemic factors have an impact on its development, this pro-
cess always involves smooth muscle cells located in the tunica media of the 
saphenous vein segment [28]. Smooth muscle cells release matrix metallo-
proteinases (MMPs) that degrade extracellular matrix [29]. Th ey also produce 
tissue inhibitors of metalloproteinases (TIMPs), and a balance between MMPs 
and TIMPs eventually determines the local homeostasis of the extracellular 
matrix [30]. In research by Perek et al. (2016) evaluating the expression of 
proteins, the majority of saphenous vein segments exhibited weak or moderate 
immunostaining of MMP-2, TIMP-2 and TIMP-3 within the tunica media. Th e 
tissue expression of MMP-2 and TIMPs has been associated with the age of the 
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patients [31]. Th e degradation of extracellular matrix by MMPs, which provides 
a structural framework essential for the functional properties of vessel wall, 
was found to be a prerequisite for smooth muscle cells migration, a critical step 
in neointima formation [27]. Moreover, baseline level of MMP-2 in the saphen-
ous vein wall was shown to have a strong linear correlation with the degree of 
luminal narrowing at 1 year aft er coronary artery bypass graft  [32]. Perek et al. 
(2016) stated that saphenous vein segments may be more appropriate graft s 
in the elderly population. Moreover, their study also demonstrated increased 
tissue activity of TIMP-2 and TIMP-3 in the tunica media of the saphenous 
vein segments [31]. However, no correlation between the age of the patient and 
TIMP-2 activity in the human aortic specimen had been demonstrated [33]. 
Th erefore, it has been suggested that TIMP-3 is a senescence-related protein 
[34]. Heavy smoking also noticeably increases native MMP2 and MMP9 gene 
expression in the saphenous vein before coronary artery bypass graft . Even 
aft er long-term cessation of smoking, the dysregulated MMP2 and MMP9 gene 
expression cannot recover to normal levels. With the elevated native MMP2 
and MMP9 gene expression in the saphenous vein induced by heavy smoking, 
more vein graft  disease can be found on long-term follow-up [35].
HGF is not a signifi cant factor in the v.saphena magna wall, because as 
Gallo et al. (2015) stated, the HGF and its receptor Met pathway has a promi-
nent role in cardiovascular remodelling aft er tissue injury [36]. However, the 
abundant deposits of TGFβ, VCAM and ICAM are important for the mainte-
nance of large vein homeostasis. George et al. (2005) suggest that the amount 
of TGFβ in human saphenous vein is suffi  cient, when in the active form, to 
protect smooth muscle cells against apoptosis. Decreasing the amount of active 
TGFβ causes smooth muscle cells to undergo apoptosis, but adding exogenous 
TGFβ has no benefi cial eff ect [37], while gene expression of MMP9, MMP12, 
TIMP1 and TIMP2 is infl uenced by the addition of TGF-β1. Th ese results may 
be translated to chronic venous insuffi  ciency framework and suggest involve-
ment of TGF-β1 in the vein wall pathology [38]. 
Saphenous veins used as coronary artery bypass graft s have a specifi c dis-
tribution of the expression of the adhesion molecules ICAM-1 and VCAM-1. 
Th ese molecules, which belong to the immunoglobulin superfamily, medi-
ate adhesion and transmigration of blood leukocytes through the endothe-
lium. Th e adhesion of all leukocytes is mediated by the expression of ICAM-1, 
whereas VCAM-1 is specifi c for lymphocytes, monocytes, and eosinophils. 
Adhesion of blood elements to the endothelium is an important step in the 
development of vein graft  disease [39]. Th e endothelium is immunoregulatory 
in that inhibiting the function of vascular adhesion molecules blocks  leukocyte 
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recruitment and, thus, tissue infl ammation. Endothelium is stimulated to 
express adhesion molecules that mediate leukocyte binding. Upon leukocyte 
binding, these adhesion molecules activate endothelial cell signal transduction 
that then alters endothelial cell shape for the opening of passageways through 
which leukocytes can migrate. If the stimulation of this opening is blocked, 
infl ammation is blocked. VCAM-1 on the endothelium functions as both a 
scaff old for leukocyte migration and a trigger of endothelial signalling [40]. 
V. saphena magna is not richly innervated with neuropeptide-containing 
nerve fi bres. Gulbenkian et al. (1987) discovered that, in the vascular system of 
guinea pigs, PGP 9.5 immunoreactivity occurred in an extensive plexus of fi ne 
perivascular nerve fi bres and fascicles running around and along both arteries 
and veins, mainly at the adventitial-medial border [41]. Th is shows that only 
the fascicles of nerve fi bres enter the wall of the vein.
CONCLUSIONS
V. saphena magna used for coronary artery bypass surgery possess a moderate 
number of VEGF and MMP positive cells with slightly more TIMP immu-
noreactive cells suggesting the connective tissue remodellation and presence 
of tissue ischemia. Healthy v. saphena magna is characterised by rich expres-
sion of TGFβ, VCAM and ICAM structures. HGF seems not to be involved in 
homeostasis regulation of these blood vessels which are slightly innervated by 
neuropeptide containing nerves.
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